Linzagolix
- Product Name
- Linzagolix
- CAS No.
- 935283-04-8
- Chemical Name
- Linzagolix
- Synonyms
- OBE2109;RMA-895;OBE 2109;OBE-2109;Linzagolix;Linzagolix CAS;Zavegepant Impurity 55;Linzagolix, 10 mM in DMSO;3-{5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl}-2,4-dioxo-1H,2H,3H,4H-thieno[3,4-d]pyrimidine-5-carboxylic acid;3-(5-((2,3-difluoro-6-methoxybenzyl)oxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid
- CBNumber
- CB54844986
- Molecular Formula
- C22H15F3N2O7S
- Formula Weight
- 508.42
- MOL File
- 935283-04-8.mol
Linzagolix Property
- storage temp.
- Store at -20°C
- solubility
- DMSO : 125 mg/mL (245.86 mM; Need ultrasonic)
- form
- Solid
- color
- White to light brown
- InChIKey
- BMAAMIIYNNPHAB-UHFFFAOYSA-N
- SMILES
- C1(=O)N(C2=CC(OCC3=C(OC)C=CC(F)=C3F)=C(OC)C=C2F)C(=O)C2=C(C(O)=O)SC=C2N1
Linzagolix Chemical Properties,Usage,Production
Uses
Linzagolix (KLH-2109; OBE-2109) is a potent, non-peptide, and orally active GnRH antagonist. Linzagolix can be used for uterine fibroids, endometriosis, adenomyosis research[1][2][3].
in vivo
Linzagolix (50 mg/kg) reduces cyst volume in a rat model of endometriosis[1].
Lindagolix reduces serum luteinizing hormone and testosterone levels in male rats and dogs with normal or BPH models[2].
| Animal Model: | Endometriosis model rat[1] |
| Dosage: | 50 mg/kg |
| Administration: | |
| Result: | Reduced cyst volume. |
References
[1] Motohiro Tezuka, et al. Suppressive effects of linzagolix, a novel non-peptide antagonist of gonadotropin-releasing hormone receptors, in experimental endometriosis model rats. Clin Exp Pharmacol Physiol. 2023 Jul;50(7):610-617. DOI:10.1111/1440-1681.13778
[2] Motohiro Tezuka, et al. Suppression of hypothalamic-pituitary-gonadal function by linzagolix in benign prostatic hyperplasia and polycystic ovary syndrome animal models. Clin Exp Pharmacol Physiol. 2023 Nov;50(11):914-923. DOI:10.1111/1440-1681.13817
[3] Susan Dababou, et al. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opin Investig Drugs. 2021 Sep;30(9):903-911. DOI:10.1080/13543784.2021.1957830
Linzagolix Preparation Products And Raw materials
Raw materials
Preparation Products
Linzagolix Suppliers
- Tel
- 0571-86828652 18857119830
- Fax
- 0571-83522824
- sales@chemtrue-bio.com
- Country
- China
- ProdList
- 258
- Advantage
- 58
- Tel
- 0797-2111676 18890136722
- sales@chiralsyn.com
- Country
- China
- ProdList
- 110
- Advantage
- 58
- Tel
- 15727060112
- yutianchun2007@126.com
- Country
- China
- ProdList
- 9815
- Advantage
- 58
- Tel
- 14782051321 14782051321
- market@lifebiology.cn
- Country
- China
- ProdList
- 162
- Advantage
- 58
- Tel
- 027-59102966 18717199209
- 2853877583@QQ.com
- Country
- China
- ProdList
- 7556
- Advantage
- 58
- Tel
- 17702719238 18971495150;
- sales@sun-shinechem.com
- Country
- China
- ProdList
- 1112
- Advantage
- 64
- Tel
- 025-83697070 13913916777;
- Fax
- +86-25-83453306
- info@chemlin.com.cn
- Country
- China
- ProdList
- 15724
- Advantage
- 64
- Tel
- 025-57798810
- Fax
- 025-57019371
- sales@sunlidabio.com
- Country
- China
- ProdList
- 3239
- Advantage
- 55
- Tel
- 400-400-164-7117 18317119277
- Fax
- +86-21-61629029
- product02@bidepharm.com
- Country
- China
- ProdList
- 40000
- Advantage
- 60
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4800
- Advantage
- 55
View Lastest Price from Linzagolix manufacturers
- Product
- Linzagolix 935283-04-8
- Price
- US $5.00-0.50/KG
- Min. Order
- 1KG
- Purity
- 99% hplc
- Supply Ability
- 500TONS
- Release date
- 2025-06-05
- Product
- Linzagolix 935283-04-8
- Price
- US $0.00-0.00/mg
- Min. Order
- 10mg
- Purity
- 98
- Supply Ability
- 10000000
- Release date
- 2025-02-17
- Product
- Linzagolix 935283-04-8
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- 98% HPLC
- Supply Ability
- 100kg
- Release date
- 2023-08-14